Breast cancer drug approved after UK pharma deal with Trump

Medicine previously rejected by watchdog in England on cost grounds will now be available to about 1,000 women a year

阅读完整 Veytics 简报

我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。